IT7927284A0 - 5- (2-imidazolin-2-il)-aminopirimidine sostituite e processo per la loro preparazione. - Google Patents

5- (2-imidazolin-2-il)-aminopirimidine sostituite e processo per la loro preparazione.

Info

Publication number
IT7927284A0
IT7927284A0 IT7927284A IT2728479A IT7927284A0 IT 7927284 A0 IT7927284 A0 IT 7927284A0 IT 7927284 A IT7927284 A IT 7927284A IT 2728479 A IT2728479 A IT 2728479A IT 7927284 A0 IT7927284 A0 IT 7927284A0
Authority
IT
Italy
Prior art keywords
imidazolin
preparation
substituted aminopyrimidines
aminopyrimidines
substituted
Prior art date
Application number
IT7927284A
Other languages
English (en)
Other versions
IT1127225B (it
Inventor
Stenzel Wolfgang
Cohnen Erich
Fleck Wolfgang
Armah Ben
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2849537A external-priority patent/DE2849537C2/de
Priority claimed from DE19792937023 external-priority patent/DE2937023A1/de
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Publication of IT7927284A0 publication Critical patent/IT7927284A0/it
Application granted granted Critical
Publication of IT1127225B publication Critical patent/IT1127225B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT27284/79A 1978-11-15 1979-11-14 5-(2-imidazolin-2-il)-aminopirimidine sostituite e processo per la loro preparazione IT1127225B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2849537A DE2849537C2 (de) 1978-11-15 1978-11-15 Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19792937023 DE2937023A1 (de) 1979-09-13 1979-09-13 Neue substituierte 5-(2-imidazolin-2-yl)-aminopyrimidine und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
IT7927284A0 true IT7927284A0 (it) 1979-11-14
IT1127225B IT1127225B (it) 1986-05-21

Family

ID=25776489

Family Applications (1)

Application Number Title Priority Date Filing Date
IT27284/79A IT1127225B (it) 1978-11-15 1979-11-14 5-(2-imidazolin-2-il)-aminopirimidine sostituite e processo per la loro preparazione

Country Status (12)

Country Link
US (1) US4323570A (it)
AT (1) AT374197B (it)
AU (1) AU541305B1 (it)
CA (1) CA1138454A (it)
CH (1) CH642965A5 (it)
DK (1) DK150142C (it)
ES (1) ES486349A1 (it)
FR (1) FR2441625A1 (it)
GB (1) GB2039275B (it)
IT (1) IT1127225B (it)
NL (2) NL190553C (it)
SE (1) SE440079B (it)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2146986B (en) * 1983-09-23 1987-06-17 Lilly Co Eli Process for preparing 5-substituted pyrimidines
DE3729299A1 (de) * 1987-09-02 1989-03-23 Beiersdorf Ag Transdermales therapeutisches system
DE3739779A1 (de) * 1987-11-24 1989-06-08 Beiersdorf Ag Pharmazeutische praeparate
DE3904795C2 (de) * 1989-02-17 2000-10-12 Lilly Pharma Produktion Gmbh & Pharmazeutisches Präparat und dessen Verwendung
DE4423177A1 (de) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglykämisch wirksame Arzneimittel
US5972948A (en) * 1994-07-01 1999-10-26 Solvay Pharmaceuticals Gmbh Method of inhibiting hyperglycemia and pharmaceutical composition for use therein
US5977121A (en) * 1995-02-28 1999-11-02 Eli Lilly And Company Use of moxonidine for the treatment of atherosclerosis
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
IL118544A (en) * 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
CA2182851A1 (en) * 1995-08-15 1997-02-16 August Masaru Watanabe Method for treating substance abuse withdrawal
AU3233197A (en) * 1996-06-06 1998-01-05 Eli Lilly And Company Formulation and method for treating congestive heart failure
NO980546L (no) * 1997-02-11 1998-08-12 Lilly Co Eli Farmas°ytiske midler
DE19722322A1 (de) * 1997-05-28 1998-12-03 Solvay Pharm Gmbh Nephroprotektives Arzneimittel
EP0954316A4 (en) * 1997-09-03 2002-02-13 Lilly Co Eli PYRIMIDINE DERIVATIVES
DE19911371A1 (de) 1999-03-15 2000-09-21 Solvay Pharm Gmbh Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen
CA2487541A1 (en) * 2002-06-19 2003-12-31 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
CN101370500A (zh) * 2006-01-27 2009-02-18 弗·哈夫曼-拉罗切有限公司 2-咪唑化合物用于治疗cns障碍的用途
DE602006002738D1 (de) * 2006-06-26 2008-10-23 Chemagis Ltd Verbessertes Verfahren zur Herstellung von Moxonidine
ATE411310T1 (de) * 2006-06-26 2008-10-15 Chemagis Ltd Reinigungsverfahren von moxonidine
EP1894926A1 (en) * 2006-06-26 2008-03-05 Chemagis Ltd. Polymorphs of moxonidine and processes for preparation therefor
WO2008020425A1 (en) * 2006-08-17 2008-02-21 Chemagis Ltd. Crystalline moxonidine comprising single tautomer and preparation process therefor
DE602006018139D1 (de) * 2006-08-31 2010-12-23 Chemagis Ltd Verwendung der Monoxidinssalze zur Reinigung von Monoxidin
RU2009112495A (ru) * 2006-10-19 2010-11-27 Ф. Хоффманн-Ля Рош Аг (Ch) Аминометил-2-имидазолы со сродством к рецепторам, ассоциированным со следовыми аминами
CN101528710B (zh) * 2006-10-19 2012-11-07 弗·哈夫曼-拉罗切有限公司 氨基甲基-4-咪唑类
EP2086959B1 (en) * 2006-11-02 2011-11-16 F. Hoffmann-La Roche AG Substituted 2-imidazoles as modulators of the trace amine associated receptors
CA2669112A1 (en) * 2006-11-16 2008-05-22 F. Hoffmann-La Roche Ag Substituted 4-imidazoles
WO2008073125A1 (en) * 2006-12-12 2008-06-19 Chemagis Ltd. Moxonidine analogs, preparation processes and uses therefor
ATE509628T1 (de) * 2006-12-13 2011-06-15 Hoffmann La Roche Neue 2-imidazole als liganden für trace amine associated receptors (taar)
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
BRPI0806940A2 (pt) 2007-02-02 2014-05-06 Hoffmann La Roche 2-amino-oxazolinas como ligantes taar1 para distúrbios do snc
CA2676944C (en) * 2007-02-15 2016-01-19 F. Hoffmann-La Roche Ag 2-aminooxazolines as taar1 ligands
CA2691082A1 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
WO2009003867A1 (en) * 2007-07-03 2009-01-08 F. Hoffmann-La Roche Ag 4-imidazolines and their use as antidepressants
BRPI0813837A2 (pt) * 2007-07-27 2015-01-06 Hoffmann La Roche 2-azetidinametanoaminas e 2-pirrolidinametanoaminas como ligantes de taar
AU2008281877A1 (en) * 2007-08-02 2009-02-05 F. Hoffmann-La Roche Ag The use of benzamide derivatives for the treatment of CNS disorders
KR101167773B1 (ko) * 2007-08-03 2012-07-24 에프. 호프만-라 로슈 아게 Ｔａａｒ１ 리간드로서의 피리딘카복스아마이드 및 벤즈아마이드 유도체
EP2321287B1 (en) * 2008-07-24 2015-11-11 F. Hoffmann-La Roche AG 4,5-dihydro-oxazol-2-yl derivatives
US8242153B2 (en) * 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US20100311798A1 (en) * 2009-06-05 2010-12-09 Decoret Guillaume 2-aminooxazolines as taar1 ligands
US8354441B2 (en) * 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
EP2586779A1 (en) 2011-10-24 2013-05-01 Hetero Research Foundation Process for the preparation of moxonidine
DE102012215896A1 (de) * 2012-09-07 2014-03-13 Wörwag Pharma GmbH & Co.KG Moxonidinsynthese mit Hilfe organischer Basen
EP2738165B1 (en) 2012-12-03 2016-10-12 WÖRWAG PHARMA GmbH & Co. KG Method by means of phase transfer catalysis
EP2765131B1 (en) 2013-02-08 2016-11-23 Arevipharma GmbH Process for the production of Moxonidine
WO2014140034A1 (en) * 2013-03-14 2014-09-18 Farmak, A.S. Improved process for the manufacture of moxonidine
EP2829540A1 (en) 2013-07-26 2015-01-28 Abbott Healthcare Products B.V. Synthesis of substituted aminopyridines
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
KR102537050B1 (ko) 2016-03-17 2023-05-26 에프. 호프만-라 로슈 아게 Taar의 작용제로서 활성을 갖는 5-에틸-4-메틸-피라졸-3-카복스아미드 유도체
JP2023549394A (ja) 2020-11-12 2023-11-24 スリールセータ エーハゥーエッフ 注意欠陥／多動性障害の新規な治療

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754832A (fr) 1969-08-14 1971-02-15 Beecham Group Ltd Iminazolines
GB1319840A (en) * 1970-08-27 1973-06-13 Beecham Group Ltd Substituted 5-amino imidazoles
BE795636A (fr) * 1972-02-19 1973-08-20 Schering Ag Nitroimidazolylpyrimidines, et leur procede de preparation
US4029792A (en) * 1972-02-29 1977-06-14 Pfizer Inc. (2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents
DE2220906A1 (de) * 1972-04-28 1973-11-15 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung
BE503170A (it) * 1975-09-02

Also Published As

Publication number Publication date
NL7908192A (nl) 1980-05-19
DK150142C (da) 1987-06-01
DK150142B (da) 1986-12-15
US4323570A (en) 1982-04-06
SE440079B (sv) 1985-07-15
CH642965A5 (de) 1984-05-15
NL940011I2 (nl) 1998-05-06
SE7909392L (sv) 1980-05-16
CA1138454A (en) 1982-12-28
ATA727079A (de) 1983-08-15
ES486349A1 (es) 1980-06-16
GB2039275B (en) 1982-11-17
FR2441625A1 (fr) 1980-06-13
NL190553C (nl) 1994-04-18
FR2441625B1 (it) 1981-12-31
IT1127225B (it) 1986-05-21
AT374197B (de) 1984-03-26
AU541305B1 (en) 1985-01-03
DK481879A (da) 1980-05-16
GB2039275A (en) 1980-08-06
NL190553B (nl) 1993-11-16
NL940011I1 (nl) 1994-08-01

Similar Documents

Publication Publication Date Title
IT7927284A0 (it) 5- (2-imidazolin-2-il)-aminopirimidine sostituite e processo per la loro preparazione.
IT7922264A0 (it) Processo per la formazione di peci in neomesofase.
IT7828495A0 (it) Nuovi pigmenti inorganici e processo per prepararli.
IT7924131A0 (it) Gasolio. processo per la preparazione di
IT1094039B (it) Processo per la preparazione di 2,2,6,6-tetrametil-4-piperidone
BE880042A (fr) 5-(2-imidazolin-2-yl)-aminopyrimidines substituees et leur procede de preparation.
BR8001091A (pt) Processo de transferencia de um guindaste
IT7921092A0 (it) Processo per la determinazione di alfa-amilasi.
BR7904352A (pt) Composto,composicao herbicida,e processo herbicida
IT7920516A0 (it) Processo di deparaffinazione.
IT7927410A0 (it) Composizione e processo.
IT7922106A0 (it) Processo per la preparazione di mullite.
BR7904057A (pt) Processo fisico-bioquimico
IT8021089A0 (it) Furani arilsostituiti e processo per la loro preparazione.
IT1113343B (it) Processo per la preparazione di 1,5-dimetibicicl(3.2.1)ottanol-8
IT7823146A0 (it) Benzenesolfoniluree e processo per la loro preparazione.
IT7822440A0 (it) N-fenilformamidossime sostituite e processo per la loro preparazione.
IT7927992A0 (it) Processo per preparare polimetilenpolifenil policarbammati.
BR7907758A (pt) Processo de preparacao de 2,3-dihidro-2,2-dimetil-7-hidroxi-benzofurano
IT1126432B (it) Esaidro-2,6-metano-3-benzazocine e processo di loro preparazione
IT1097538B (it) Processo per la preparazione del 2,6-dimetil-4-3(3-nitrofenil)-3-metossicarbonil-1,4-didropiridin-5-carbossilati di 2(n-benzil-n-metilammino)
IT1117791B (it) Perfezionamento nelle punte di trivellazione e procedimento per la loro fabbricazione
IT7830943A0 (it) 4-carbetossi-carbonilamino-pirimidi ne e processo per la loro preparazione.
IT7927991A0 (it) Processo per preparare polimetilenpolifenil policarbammati.
IT7824078A0 (it) Composti azotati eterociclici e processo per la loro preparazione.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971126